Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Alprazolam measurement (procedure) |
Component |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing alprazolam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam poisoning |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Accidental alprazolam poisoning |
Causative agent (attribute) |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Intentional alprazolam poisoning |
Causative agent (attribute) |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
intoxication par l'alprazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam adverse reaction |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Allergy to alprazolam |
Causative agent (attribute) |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Accidental alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Intentional alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
surdose d'alprazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 1mg/ml concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Product containing precisely alprazolam 250 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 1 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 2 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Accidental alprazolam poisoning |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Intentional alprazolam poisoning |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Measurement of alprazolam in serum specimen |
Component |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
2 |
Allergy to alprazolam |
Causative agent (attribute) |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam (substance) |
Inferred relationship |
Some |
|
Alprazolam 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 250 microgram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 250 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 2 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 2 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing only alprazolam in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing alprazolam in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 1 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Alprazolam- and propranolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
2 |
Product containing only alprazolam and propranolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
2 |
Alprazolam- and propranolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
2 |
Alprazolam and propranolol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |
Measurement of alprazolam in serum specimen |
Component |
True |
Alprazolam (substance) |
Inferred relationship |
Some |
1 |